Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hims & Hers Health, Inc.HIMS · Entity 1878 | Director | August 14, 2026 | August 18, 2026 |
| NETFLIX INCNFLX · Entity 403 | CFO | January 02, 2019 | January 04, 2019 |
| Trade Desk, Inc.TTD · Entity 3752 | Director | May 13, 2025 | May 15, 2025 |
| Wise Group plcWSE · Entity 3428 | Director | May 08, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hims & Hers Health, Inc.
Report date August 14, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 229,808 |
Reported balance
After 2026-08-14 transaction · row 1
1 source rowRow 1 · 2026-08-14 · Exercise / conversion · Acquired 778 · Balance 229,808 F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-08-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-14 · Exercise / conversion · Disposed 778 · Balance 0 F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. F2: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,760 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
F2: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,760 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.
NETFLIX INC
Report date January 02, 2019 · Filed January 04, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $267.66 · Expires 2029-01-02 | Direct | 1,907 |
Reported balance
After 2019-01-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-01-02 · Grant · Acquired 1,907 · Balance 1,907 |
Trade Desk, Inc.
Report date May 13, 2025 · Filed May 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 66,985 |
Ending reported balance
After 2025-05-13 transaction · row 13
13 source rows · reconciled sequenceRow 1 · 2025-05-13 · Exercise / conversion · Acquired 6,990 · Balance 73,975 Row 2 · 2025-05-13 · Exercise / conversion · Acquired 1,390 · Balance 75,365 Row 3 · 2025-05-13 · Exercise / conversion · Acquired 670 · Balance 76,035 Row 4 · 2025-05-13 · Exercise / conversion · Acquired 220 · Balance 76,255 Row 5 · 2025-05-13 · Exercise / conversion · Acquired 6,826 · Balance 83,081 Row 6 · 2025-05-13 · Exercise / conversion · Acquired 1,365 · Balance 84,446 Row 7 · 2025-05-13 · Exercise / conversion · Acquired 655 · Balance 85,101 Row 8 · 2025-05-13 · Exercise / conversion · Acquired 218 · Balance 85,319 Row 9 · 2025-05-13 · Exercise / conversion · Acquired 7,282 · Balance 92,601 Row 10 · 2025-05-13 · Exercise / conversion · Acquired 1,374 · Balance 93,975 Row 11 · 2025-05-13 · Exercise / conversion · Acquired 1,374 · Balance 95,349 Row 12 · 2025-05-13 · Exercise / conversion · Acquired 274 · Balance 95,623 Row 13 · 2025-05-13 · Sale · Disposed 28,638 · Balance 66,985 F1: These sales represent the aggregate shares from the twelve acquisitions reported above. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.88 to $79.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.46 · Expires 2031-05-27 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2025-05-13 · Exercise / conversion · Disposed 6,990 · Balance 0 F3: This option was previously reported as covering 699 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F4: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.46 · Expires 2031-05-27 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2025-05-13 · Exercise / conversion · Disposed 1,390 · Balance 0 F5: This option was previously reported as covering 139 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F4: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.46 · Expires 2031-05-27 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2025-05-13 · Exercise / conversion · Disposed 670 · Balance 0 F6: This option was previously reported as covering 67 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F7: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.46 · Expires 2031-05-27 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2025-05-13 · Exercise / conversion · Disposed 220 · Balance 0 F8: This option was previously reported as covering 22 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F9: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2032-05-26 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2025-05-13 · Exercise / conversion · Disposed 6,826 · Balance 0 F10: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2032-05-26 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2025-05-13 · Exercise / conversion · Disposed 1,365 · Balance 0 F10: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2032-05-26 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · 2025-05-13 · Exercise / conversion · Disposed 655 · Balance 0 F11: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2032-05-26 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · 2025-05-13 · Exercise / conversion · Disposed 218 · Balance 0 F12: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.26 · Expires 2033-05-25 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · 2025-05-13 · Exercise / conversion · Disposed 7,282 · Balance 0 F13: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.26 · Expires 2033-05-25 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · 2025-05-13 · Exercise / conversion · Disposed 1,374 · Balance 0 F13: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.26 · Expires 2033-05-25 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 24
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 24 · 2025-05-13 · Exercise / conversion · Disposed 1,374 · Balance 0 F14: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.26 · Expires 2033-05-25 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 25
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 25 · 2025-05-13 · Exercise / conversion · Disposed 274 · Balance 0 F15: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. |
Filing footnotes · ownership attribution and instrument terms
F1: These sales represent the aggregate shares from the twelve acquisitions reported above.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.88 to $79.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3: This option was previously reported as covering 699 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
F4: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
F5: This option was previously reported as covering 139 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
F6: This option was previously reported as covering 67 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
F7: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
F8: This option was previously reported as covering 22 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
F9: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.
F10: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
F11: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
F12: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.
F13: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
F14: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
F15: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.
Wise Group plc
Report date May 08, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Expires 2029-02-27 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-05-08 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F2: The initial exercise price for the option award was 0.6192 GBP. In connection with the effectiveness of the Issuer's Scheme of Arrangement on May 8, 2026, the option award was assumed by the Issuer and the exercise price thereof was converted from British pound sterling to U.S. dollars using a mid-market exchange rate on May 8, 2026, which is not yet available as of the time of this initial statement of beneficial ownership of securities. The Reporting Person undertakes to provide in a subsequent statement of changes in beneficial ownership full information regarding the exercise price for the option award following the conversion described above. F1: Fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Fully vested and exercisable.
F2: The initial exercise price for the option award was 0.6192 GBP. In connection with the effectiveness of the Issuer's Scheme of Arrangement on May 8, 2026, the option award was assumed by the Issuer and the exercise price thereof was converted from British pound sterling to U.S. dollars using a mid-market exchange rate on May 8, 2026, which is not yet available as of the time of this initial statement of beneficial ownership of securities. The Reporting Person undertakes to provide in a subsequent statement of changes in beneficial ownership full information regarding the exercise price for the option award following the conversion described above.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2024 Filed Jun 18, 2024 21:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 894 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000202 · wk-form4_1718746051.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,787 Underlying: Class A Common Stock · 894 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000202 · wk-form4_1718746051.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,267 Underlying: Class A Common Stock · 9,134 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 10,046 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-24-000202 · wk-form4_1718746051.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 19,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000181 · wk-form4_1718051872.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 19,707 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2024 annual meeting of stockholders or (b) June 15, 2024. F2 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2024 annual meeting of stockholders or (b) June 15, 2024. F2 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2024 annual meeting of stockholders or (b) June 15, 2024. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 19,707 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-24-000181 · wk-form4_1718051872.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The RSUs vested on June 6, 2024, the date of the company's 2024 annual stockholders meeting. Read SEC document |
| May 28, 2024 Filed May 30, 2024 22:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantClass A Common Stock | 114 | $87.16 | $9,936.24 |
DisclosureSEC source: 0001671933-24-000071 · wk-form4_1717106727.xml · nonDerivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,485 F6 · shares: Grant of restricted stock award under the Issuer's 2016 Equity Incentive Plan. The shares vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. F4 · price: This price represents the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of restricted stock awards granted. F7 · price: This restricted stock award was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $10,000. Read SEC document |
| May 28, 2024 Filed May 30, 2024 22:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantClass A Common Stock | 573 | $87.16 | $49,942.68 |
DisclosureSEC source: 0001671933-24-000071 · wk-form4_1717106727.xml · nonDerivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,371 F5 · shares: Grant of restricted stock award under the Issuer's 2016 Equity Incentive Plan. The shares vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. F3 · price: This restricted stock award was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $50,000. F4 · price: This price represents the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of restricted stock awards granted. Read SEC document |
| May 28, 2024 Filed May 30, 2024 22:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantClass A Common Stock | 573 | $87.16 | $49,942.68 |
DisclosureSEC source: 0001671933-24-000071 · wk-form4_1717106727.xml · nonDerivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,798 F1 · shares: Grant of restricted stock award under the Issuer's 2016 Equity Incentive Plan. The shares vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. F3 · price: This restricted stock award was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $50,000. F4 · price: This price represents the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of restricted stock awards granted. Read SEC document |
| May 28, 2024 Filed May 30, 2024 22:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantClass A Common Stock | 3,155 | $0.00 | $0.00 |
DisclosureSEC source: 0001671933-24-000071 · wk-form4_1717106727.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,225 F1 · shares: Grant of restricted stock award under the Issuer's 2016 Equity Incentive Plan. The shares vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. F2 · price: This restricted stock award was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000078 · wk-form4_1710885767.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54 Underlying: Class A Common Stock · 17 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 893 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000078 · wk-form4_1710885767.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,681 Underlying: Class A Common Stock · 893 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000078 · wk-form4_1710885767.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,401 Underlying: Class A Common Stock · 9,134 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 10,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-24-000078 · wk-form4_1710885767.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:05 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 260,000 | $13.16 | $3,421,210.00 |
DisclosureSEC source: 0001773751-24-000040 · wk-form4_1709327135.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,195 F1 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.15 - $13.2201. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 21:55 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000302 · wk-form4_1703022926.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71 Underlying: Class A Common Stock · 18 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 21:55 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 894 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000302 · wk-form4_1703022926.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,574 Underlying: Class A Common Stock · 894 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 21:55 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000302 · wk-form4_1703022926.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,535 Underlying: Class A Common Stock · 9,133 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 21:55 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 10,045 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-23-000302 · wk-form4_1703022926.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 406,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 18:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000249 · wk-form4_1695147096.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89 Underlying: Class A Common Stock · 18 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 18:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 893 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000249 · wk-form4_1695147096.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,468 Underlying: Class A Common Stock · 893 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 18:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000249 · wk-form4_1695147096.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,668 Underlying: Class A Common Stock · 9,134 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 18:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 10,045 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-23-000249 · wk-form4_1695147096.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 396,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| August 09, 2023 Filed Aug 16, 2023 21:34 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 19,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000213 · wk-form4_1692221651.xml · derivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,707 Underlying: Class A Common Stock · 19,707 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2024 annual meeting of stockholders or (b) June 15, 2024. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2024 annual meeting of stockholders or (b) June 15, 2024. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2024 annual meeting of stockholders or (b) June 15, 2024. Read SEC document |
| July 13, 2023 Filed Jul 13, 2023 21:00 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass A Common Stock | 5,000 | $90.00 | $450,000.00 |
DisclosureSEC source: 0001209191-23-042233 · doc4.xml · nonDerivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,070 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 22, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 11, 2023 Filed Jul 13, 2023 21:00 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass A Common Stock | 12,500 | $80.00 | $1,000,000.00 |
DisclosureSEC source: 0001209191-23-042233 · doc4.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,070 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 22, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 21:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000179 · wk-form4_1687294954.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107 Underlying: Class A Common Stock · 18 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 21:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 894 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000179 · wk-form4_1687294954.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,361 Underlying: Class A Common Stock · 894 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 21:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000179 · wk-form4_1687294954.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,802 Underlying: Class A Common Stock · 9,134 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 21:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 10,046 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-23-000179 · wk-form4_1687294954.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 25,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000150 · wk-form4_1685739839.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 25,659 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The RSUs vested on June 1, 2023, the date of the company's 2023 annual stockholder meeting. F1 · derivative.exercise_date: The RSUs vested on June 1, 2023, the date of the company's 2023 annual stockholder meeting. F1 · derivative.expiration_date: The RSUs vested on June 1, 2023, the date of the company's 2023 annual stockholder meeting. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 25,659 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-23-000150 · wk-form4_1685739839.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 376,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The RSUs vested on June 1, 2023, the date of the company's 2023 annual stockholder meeting. Read SEC document |
| May 30, 2023 Filed May 30, 2023 23:36 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass A Common Stock | 20,000 | $70.00 | $1,400,000.00 |
DisclosureSEC source: 0001209191-23-033039 · doc4.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,570 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 22, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 25, 2023 Filed May 30, 2023 23:36 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantStock Option (Right to Buy) · Derivative | 274 | $36.39 Strike: $66.26 | $9,970.86 |
DisclosureSEC source: 0001209191-23-033039 · doc4.xml · derivative · entry 5 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 274 Underlying: Class A Common Stock · 274 shares Expires 2033-05-25 F5 · price: This price represents the Black-Scholes value of an option using the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of shares subject to the option granted. F9 · price: The option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $10,000. F8 · derivative.exercise_date: Grant of option to purchase Class A Common Stock under the Issuer's 2016 Equity Incentive Plan. The shares subject to the option vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. Read SEC document |
| May 25, 2023 Filed May 30, 2023 23:36 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantStock Option (Right to Buy) · Derivative | 1,374 | $36.39 Strike: $66.26 | $49,999.86 |
DisclosureSEC source: 0001209191-23-033039 · doc4.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,374 Underlying: Class A Common Stock · 1,374 shares Expires 2033-05-25 F5 · price: This price represents the Black-Scholes value of an option using the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of shares subject to the option granted. F6 · price: The option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $50,000. F7 · derivative.exercise_date: Grant of option to purchase Class A Common Stock under the Issuer's 2016 Equity Incentive Plan. The shares subject to the option vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. Read SEC document |
| May 25, 2023 Filed May 30, 2023 23:36 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantStock Option (Right to Buy) · Derivative | 1,374 | $36.39 Strike: $66.26 | $49,999.86 |
DisclosureSEC source: 0001209191-23-033039 · doc4.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,374 Underlying: Class A Common Stock · 1,374 shares Expires 2033-05-25 F5 · price: This price represents the Black-Scholes value of an option using the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of shares subject to the option granted. F6 · price: The option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $50,000. F3 · derivative.exercise_date: Grant of option to purchase Class A Common Stock under the Issuer's 2016 Equity Incentive Plan. The shares subject to the option vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. Read SEC document |
| May 25, 2023 Filed May 30, 2023 23:36 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantStock Option (Right to buy) · Derivative | 7,282 | $0.00 Strike: $66.26 | $0.00 |
DisclosureSEC source: 0001209191-23-033039 · doc4.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,282 Underlying: Class A Common Stock · 7,282 shares Expires 2033-05-25 F4 · price: The option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant. F3 · derivative.exercise_date: Grant of option to purchase Class A Common Stock under the Issuer's 2016 Equity Incentive Plan. The shares subject to the option vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000092 · wf-form4_167908410010097.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,936 Underlying: Class A Common Stock · 9,133 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 893 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000092 · wf-form4_167908410010097.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,255 Underlying: Class A Common Stock · 893 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000092 · wf-form4_167908410010097.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125 Underlying: Class A Common Stock · 17 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 10,043 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-23-000092 · wf-form4_167908410010097.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 21:20 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 100,000 | $9.77 | $976,540.00 |
DisclosureSEC source: 0001773751-23-000054 · wf-form4_167839683833491.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,357 F1 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.75 - $9.835. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:51 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-22-000252 · wf-form4_167148664971279.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,069 Underlying: Class A Common Stock · 9,133 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:51 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 893 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-22-000252 · wf-form4_167148664971279.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,148 Underlying: Class A Common Stock · 893 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:51 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-22-000252 · wf-form4_167148664971279.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142 Underlying: Class A Common Stock · 18 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:51 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 10,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-22-000252 · wf-form4_167148664971279.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,357 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:09 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-22-000195 · wf-form4_166362896273923.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,202 Underlying: Class A Common Stock · 9,134 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:09 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 894 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-22-000195 · wf-form4_166362896273923.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,041 Underlying: Class A Common Stock · 894 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:09 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-22-000195 · wf-form4_166362896273923.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160 Underlying: Class A Common Stock · 18 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:09 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 10,046 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-22-000195 · wf-form4_166362896273923.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| August 10, 2022 Filed Aug 11, 2022 20:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 25,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-22-000182 · wf-form4_166025027428454.xml · derivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,659 Underlying: Class A Common Stock · 25,659 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs shall vest on June 15, 2023, subject to a service-based vesting requirement, which shall be satisfied on the date that is the earlier of (a) June 15, 2023 or (b) the date of the company's next-occurring annual stockholder meeting. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs shall vest on June 15, 2023, subject to a service-based vesting requirement, which shall be satisfied on the date that is the earlier of (a) June 15, 2023 or (b) the date of the company's next-occurring annual stockholder meeting. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs shall vest on June 15, 2023, subject to a service-based vesting requirement, which shall be satisfied on the date that is the earlier of (a) June 15, 2023 or (b) the date of the company's next-occurring annual stockholder meeting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.